BCL2 and acute lymphoblastic leukemia: In our dataset, the majority of cell lines were very sensitive to broad BCL2 family member inhibitors (i.e., navitoclax, sabutoclax) (Supplementary Fig. 5d, e), but for selective inhibitors of BCL family members, BCP-ALL and T-ALL cell lines were distinguished based on their sensitivity profiles.